HTD1801 in Adults With Nonalcoholic Steatohepatitis and Liver Fibrosis Who Have Type 2 Diabetes or Pre-Diabetes
Condition(s):Nonalcoholic Steatohepatitis (NASH); Type 2 DiabetesLast Updated:February 14, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Nonalcoholic Steatohepatitis (NASH); Type 2 DiabetesLast Updated:February 14, 2024Recruiting
Condition(s):Primary Biliary Cholangitis; Primary Biliary Cirrhosis; Cholangitis; Cholestasis; Biliary Tract Diseases; Bile Duct StrictureLast Updated:June 28, 2022Completed
Condition(s):Primary Sclerosing Cholangitis; Cholangitis; Cholangitis, Sclerosing; Bile Duct Diseases; Biliary Tract Diseases; Digestive System Diseases; AdolescentLast Updated:February 15, 2021Withdrawn
Condition(s):Fatty Liver, Nonalcoholic; NAFLD; Nonalcoholic Fatty Liver Disease; Nonalcoholic Steatohepatitis; Digestive System Diseases; Type 2 Diabetes Mellitus (T2DM)Last Updated:December 29, 2021Completed
Condition(s):HypercholesterolemiaLast Updated:March 3, 2023Completed
Condition(s):Primary Sclerosing Cholangitis (PSC)Last Updated:April 6, 2022Completed
Condition(s):Primary Sclerosing CholangitisLast Updated:July 27, 2020Completed
Condition(s):Type 2 Diabetes MellitusLast Updated:July 27, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.